Sales of PPA drugs may little impact to industries.

Published: 2004-08-09 06:59:00

Updated: 2004-08-09 06:59:00

The recent scandals on cold remedies containing PPA (phenylpropanolamine) may not give any serious impact to the total sales of drug companies according to an analysis of Hanyang Security Co.

The analysis indicated that the adverse impact of the recent scandal, cold remedies formulated with ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK